Document is current
Any future updates will be listed below
-
Authors
Al-Sawaf, O. http://orcid.org/0000-0001-9895-0570
Robrecht, S.
Bahlo, J.
Fink, A. M.
Cramer, P.
v Tresckow, J.
Lange, E.
Kiehl, M.
Dreyling, M.
Ritgen, M.
Dürig, J.
Tausch, E.
Schneider, C.
Stilgenbauer, S.
Wendtner, C. M.
Fischer, K.
Goede, V
Hallek, M.
Eichhorst, B.
- License Information
-
More Information
Article History
Received: 20 September 2019
Revised: 15 February 2020
Accepted: 5 March 2020
First Online: 17 March 2020
Compliance with ethical standards
:
: OA reports personal fees and non-financial support from AbbVie, Roche, Gilead, Janssen. JB reports personal fees and non-financial support from Roche. PC reports personal fees and non-financial support from Roche, Janssen, Astellas, Gilead, Mundipharma, Novartis. JD reports personal fees and non-financial support from Celgene, Janssen and Abbvie. BE reports grants and personal fees from Roche, AbbVie, Gilead, Janssen. AMF reports personal fees from Janssen Pharmaceutical. KF reports non-financial support and personal fees from Roche and Abbvie. VG reports personal fees and non-financial support from Roche, Gilead, Janssen. MH reports personal fees and non-financial support from AbbVie, Roche, Gilead, Janssen, personal fees from Celgene, Boehringer Ingelheim. MR reports grants and personal fees from Roche/AbbVie. <b>StSt</b> reports grants, personal fees and non-financial support from AbbVie, Roche; grants, personal fees and non-financial support from Amgen, AstraZeneca, Celgene, Gilead, GSK, Janssen, Novartis, Pharmacyclics, Sunesis. ET reports personal fees from Roche, AbbVie. CMW reports grants and/or personal fees from Hoffmann-La Roche, Mundipharma, Servier; Janssen-Cilag, Novartis, Gilead, Morphosys and Abbvie. All others declare no conflict of interest.
